U.S. judge in Texas invalidates Allergan patents on Restasis

Published 9y ago

A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent. More »